EUVIMED · CrossrefJournal
Oncology Times
ISSN 0276-2234 · Ovid Technologies (Wolters Kluwer Health)
Latest articles
Trial Shows Smoking Persists During & After Cancer Treatment
IL1RAP to Overcome Treatment Resistance in Pancreatic Cancer
Remote Smoking Cessation Program Doubled Quit Rate for Cancer Patients
Adjuvant Selpercatinib Cuts Recurrence 83% in RET Fusion-Positive Lung Cancer
Harnessing Artificial Intelligence to Improve Cancer Care
Single-Fraction SBRT Shows 3-Year Disease Control in Prostate Cancer
Sildenafil Restricts Metastasis by Cutting Off Cancer Cells' Cholesterol Supply
Expanded Scope of Artificial Intelligence in Lung Cancer Imaging
FDA Finalizes Guidance to Broaden Cancer Clinical Trial Eligibility
ACOG Expands Role of Surgery in Ovarian Cancer Prevention
Daraxonrasib Approval Marks a Major Advance in Pancreatic Cancer
An Assortment of Journal Abstracts to Enhance Oncology Care
Immunotherapy Improves Survival in Localized Prostate Cancer
Personalized mRNA Vaccine Reduces Recurrence in Melanoma
Fructose Metabolism Linked to Ovarian Cancer Dissemination
Targeting an Inflammatory Enzyme Might Prevent Lung Cancer
Review Details Treatment Decisions Guided by Risk in Multiple Myeloma
Building a Bispecific Antibody Cancer Program
How Geriatric Assessment Can Help Better Guide Dose Modification in Older Adults With Cancer
FDA Updates Highlighting the Latest Cancer Treatments
Shop Talk
UpToDate®
Managing Insomnia in Breast Patients Undergoing Chemotherapy
Trust: The Next Needed Breakthrough in Colorectal Cancer
Wildfire Smoke Exposure Linked to Increased Risk for Multiple Cancers
AI Improves Accuracy of HER2-Low Breast Cancer Classification
From Barriers to Breakthroughs
Implications of Therapy-Related Clonal Hematopoiesis in Oncology Previvorship
Talking With Patients About the Other C Word
An Assortment of Journal Abstracts to Enhance Oncology Care
EUVIMED